Clinical trial
Randomized Clinical Trial to Assess Hemostasis by Applying Collagen-based Thrombin-containing Hemostat in Spinal Surgery
NCT07354178 is registered in ClinicalTrials.gov with DALIM TISSEN Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Clinical Trial to Assess Hemostasis by Applying Collagen-based Thrombin-containing Hemostat in Spinal Surgery
- Lead sponsor
- DALIM TISSEN Co., Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 22, 2024
- Completion date
- August 18, 2025
- Enrollment
- 130 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
hemostasis, intraoperative bleeding, spinal injury, spinal stenosis, spinal surgery, spinal tumor